Connect to other sites within the UBM Medica Network
Breast Cancer Family History Does Not Mean Poor Prognosis
A new study suggests that a family history of breast cancer does not result in a worse prognosis breast cancer prognosis.
FTC Brings Charges Against Four ‘Sham’ Cancer Charities
The Federal Trade Commission has charged four US cancer charities with fraud, accusing them of diverting more than $187 million in charitable donations.
DNMT3A Mutation Related to Poor-Risk AML
Patients with acute myeloid leukemia who had a DNMT3A mutation had poorer disease prognosis, according to an analysis of patients aged 60 years or younger.
New Genomic Test Improves Lung Cancer Diagnostics
A prospective study found that a bronchial airway gene-expression classifier improved the diagnostic performance of bronchoscopy for lung cancer detection.
3D Screening Can Detect More Breast Cancer Lesions
A Swedish study found that 3D tomosynthesis screening detected 40% more cases of breast cancer compared with traditional digital mammography.
Consider Breast Cancer Histology When Imaging Bone Metastases
The appearance of bone metastases on FDG PET/CT was influenced by breast cancer histology, with non-FDG-avid lesions more common in invasive lobular carcinoma patients.
ASCT Offers Survival Advantage in Elderly Multiple Myeloma Patients
Autologous stem cell transplant led to significantly longer overall survival than non-transplant strategies in a cohort of elderly patients with multiple myeloma.
Parenthood for Childhood Hodgkin Lymphoma Survivors
Women who were treated for Hodgkin lymphoma during childhood and adolescence had similar rates of post-treatment parenthood as that of the general population.
UTI Delayed Bladder Cancer Diagnosis in Medicare Population
Presentation with a urinary tract infection delayed a bladder cancer diagnosis among a population of Medicare patients, with worse delays experienced by women.
Is Radical Prostatectomy Appropriate for Very-High-Risk Prostate Cancer Patients? Yes.
At worst radical prostatectomy is equal to radiation therapy in operable very-high-risk prostate cancer, and there are accumulating data to suggest that a surgery-first approach is better induction for multimodal therapy.
By clicking Accept, you agree to become a member of the UBM Medica Community.